1 |
Juggan S, Ponnamreddy PK, JrRiley C, Dodge SE, Gilstrap LG, Zeitler EP. Comparative effectiveness of CRT in older patients with heart failure: Systematic review and meta-analysis. J Card Fail 2021:S1071-9164(21)00439-5. [PMID: 34774750 DOI: 10.1016/j.cardfail.2021.10.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
2 |
Aimo A, Fabiani I, Vergaro G, Arzilli C, Chubuchny V, Pasanisi EM, Petersen C, Poggianti E, Taddei C, Pugliese NR, Bayes-Genis A, Lupón J, Giannoni A, Ripoli A, Georgiopoulos G, Passino C, Emdin M. Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction. ESC Heart Fail 2021;8:3014-25. [PMID: 34002938 DOI: 10.1002/ehf2.13396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Li Z, Zhao H, Wang J. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med 2021;8:650278. [PMID: 34026868 DOI: 10.3389/fcvm.2021.650278] [Reference Citation Analysis]
|
4 |
Villani A, Ravaro S, Cerea P, Caravita S, Ciambellotti F, Branzi G, Munforti C, Parati G, Malfatto G. Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? J Cardiovasc Med (Hagerstown) 2020;21:682-7. [PMID: 32744827 DOI: 10.2459/JCM.0000000000001000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
5 |
Metra M. March 2019 at a glance: epidemiology and clinical trials. Eur J Heart Fail 2019;21:259-60. [PMID: 30883999 DOI: 10.1002/ejhf.1258] [Reference Citation Analysis]
|
6 |
Hawkins NM. Cardiac resynchronization therapy improves survival in selected patients with moderately impaired ejection fraction - the importance of left ventricular remodelling. Eur J Heart Fail 2019;21:370-2. [PMID: 30592366 DOI: 10.1002/ejhf.1401] [Reference Citation Analysis]
|